Effect of Acute and Chronic Tea Consumption on Platelet Aggregation in Patients With Coronary Artery Disease

Abstract—Epidemiological studies suggest that tea consumption is associated with a decreased risk of cardiovascular events, but the mechanisms of benefit remain undefined. Platelet aggregation is a precipitating event in cardiovascular disease, and tea contains antioxidant flavonoids that are known to decrease platelet aggregation in vitro. To test the effect of tea consumption on platelet aggregation, we randomized 49 patients with coronary artery disease to either 450 mL of black tea or water consumed initially, followed by 900 mL of tea or water daily for 4 weeks in a crossover design. Ex vivo platelet aggregation in platelet-rich plasma was assessed in response to ADP and thrombin receptor-activating peptide at baseline and 2 hours and 4 weeks after beverage consumption. We observed dose-dependent platelet aggregation in response to each agonist, and neither relation was altered by acute or chronic tea consumption. Plasma flavonoids increased with acute and chronic tea consumption, indicating adequate absorption of tea flavonoids. In conclusion, these results demonstrate that acute and chronic black tea consumption does not affect ex vivo platelet aggregation in patients with coronary artery disease. These findings suggest that an effect of tea flavonoids on platelet aggregation is unlikely to be the explanation for the reduction in risk of cardiovascular events noted in epidemiological studies.

[1]  J. Loscalzo,et al.  Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. , 1995, The Journal of clinical investigation.

[2]  P. Elwood,et al.  Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. , 1991, Circulation.

[3]  R. Mensink,et al.  Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. , 1998, The American journal of clinical nutrition.

[4]  C. Teng,et al.  Inhibition of platelet aggregation by some flavonoids. , 1991, Thrombosis research.

[5]  M. Steiner,et al.  Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. , 1984, Biochemical pharmacology.

[6]  J. Maclouf,et al.  Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. , 1985, Biochimica et biophysica acta.

[7]  R. Andriantsitohaina,et al.  Nitric oxide production and endothelium‐dependent vasorelaxation induced by wine polyphenols in rat aorta , 1997, British journal of pharmacology.

[8]  J. Loscalzo,et al.  Nitric oxide released from activated platelets inhibits platelet recruitment. , 1997, The Journal of clinical investigation.

[9]  E. Middleton,et al.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. , 2000, Pharmacological reviews.

[10]  P. Gazzaniga,et al.  The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. , 2000, The American journal of clinical nutrition.

[11]  Paul Knekt,et al.  Flavonoid intake and coronary mortality in Finland: a cohort study , 1996, BMJ.

[12]  F. Hsu,et al.  Inhibition of platelet activation and endothelial cell injury by flavan-3-ol and saikosaponin compounds. , 1991, Prostaglandins, leukotrienes, and essential fatty acids.

[13]  J. Freedman,et al.  alpha-Tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  M S Golden,et al.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.

[15]  P. Richardson,et al.  Alpha-tocopherol, an effective inhibitor of platelet adhesion. , 1989, Blood.

[16]  J. Stamler,et al.  N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. , 1989, Circulation research.

[17]  J. Folts,et al.  Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. , 2000, The Journal of nutrition.

[18]  A. J. King,et al.  Characteristics and occurrence of phenolic phytochemicals. , 1999, Journal of the American Dietetic Association.

[19]  E. Feskens,et al.  Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke: The Zutphen Study , 1996 .

[20]  E. Ongini,et al.  Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects. , 2000, Circulation.

[21]  J. Loscalzo,et al.  Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. , 1998, Circulation.

[22]  D. Kromhout,et al.  Chocolate as a source of tea flavonoids , 1999, The Lancet.

[23]  A. Cochrane,et al.  FACTORS ASSOCIATED WITH CARDIAC MORTALITY IN DEVELOPED COUNTRIES WITH PARTICULAR REFERENCE TO THE CONSUMPTION OF WINE , 1979, The Lancet.

[24]  Y. Yun,et al.  Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. , 1999, Thrombosis research.

[25]  J. Freedman,et al.  α‐Tocopherol and protein kinase C inhibition enhance platelet‐derived nitric oxide release , 2000 .

[26]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[27]  J. Folts,et al.  Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. , 1995, Circulation.

[28]  J. Weststrate,et al.  Bioavailability of catechins from tea: the effect of milk , 1998, European Journal of Clinical Nutrition.

[29]  A. Buczyński,et al.  Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. , 1993, Atherosclerosis.

[30]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[31]  E. Rimm,et al.  Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? , 1996, BMJ.

[32]  P C Elwood,et al.  Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. , 1997, The American journal of clinical nutrition.

[33]  C. Fraga,et al.  Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. , 2000, The Journal of nutrition.

[34]  J. Erikssen,et al.  Blood Platelet Count and Function Are Related to Total and Cardiovascular Death in Apparently Healthy Men , 1991, Circulation.

[35]  J. Cazenave,et al.  Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. , 1982, Biochemical pharmacology.

[36]  E. Rimm,et al.  Relation between Intake of Flavonoids and Risk for Coronary Heart Disease in Male Health Professionals , 1996, Annals of Internal Medicine.

[37]  A. Folsom,et al.  Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women , 1999 .

[38]  S. Renaud,et al.  Effects of alcohol on platelet functions. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[39]  H. Li,et al.  Analysis of plasma and urinary tea polyphenols in human subjects. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[41]  S. Moncada,et al.  Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.

[42]  M. Ruckstuhl,et al.  Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. , 1979, Biochemical pharmacology.

[43]  A. Hofman,et al.  Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. , 1999, Archives of internal medicine.

[44]  E. Diamandis,et al.  Wines and grape juices as modulators of platelet aggregation in healthy human subjects. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[45]  B. Halliwell,et al.  Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. , 1991, Biochemical pharmacology.

[46]  R. Gryglewski,et al.  Flavonoids are scavengers of superoxide anions. , 1988, Biochemical pharmacology.

[47]  L. Raij,et al.  Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. , 1992, The Journal of clinical investigation.

[48]  C. Keen,et al.  Cocoa inhibits platelet activation and function. , 2000, The American journal of clinical nutrition.

[49]  R. Gryglewski,et al.  On the mechanism of antithrombotic action of flavonoids. , 1987, Biochemical pharmacology.

[50]  J. Loscalzo,et al.  alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. , 1996, Circulation.

[51]  R. Handin,et al.  Enhancement of platelet function by superoxide anion. , 1977, The Journal of clinical investigation.

[52]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[53]  N. Pellegrini,et al.  Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. , 1996, European journal of clinical nutrition.

[54]  F. Oski,et al.  Hydrogen Peroxide (H2O2) an Inhibitor of the Platelet Release Reaction , 1975, Thrombosis and Haemostasis.

[55]  M. Steiner,et al.  Vitamin E. An inhibitor of the platelet release reaction. , 1976, The Journal of clinical investigation.

[56]  A. Folsom,et al.  Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. , 1999, American journal of epidemiology.

[57]  J. Loscalzo,et al.  Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. , 1996, The Journal of clinical investigation.

[58]  J. Buring,et al.  Coffee and tea intake and the risk of myocardial infarction. , 1999, American journal of epidemiology.